User profiles for Peter J. Barnes
Peter J BarnesImperial College London Verified email at imperial.ac.uk Cited by 269839 |
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
Asthma as an axon reflex
PJ Barnes - The lancet, 1986 - Elsevier
… Fuller RW, Dixon CMS, Barnes PJ. The bronchoconstrictor response to inhaled capsaicin
in humans. J Appl Physiol 1985, 85: 1080-84. Proud D, Macglashan DW, Newball HH, …
in humans. J Appl Physiol 1985, 85: 1080-84. Proud D, Macglashan DW, Newball HH, …
Chronic obstructive pulmonary disease in non-smokers
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Tobacco smoking is established as a major risk factor, but emerging evidence …
worldwide. Tobacco smoking is established as a major risk factor, but emerging evidence …
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
PJ Barnes, SD Shapiro… - European Respiratory …, 2003 - Eur Respiratory Soc
Chronic obstructive pulmonary disease is a leading cause of death and disability, but has
only recently been extensively explored from a cellular and molecular perspective. There is a …
only recently been extensively explored from a cellular and molecular perspective. There is a …
Immunology of asthma and chronic obstructive pulmonary disease
PJ Barnes - Nature Reviews Immunology, 2008 - nature.com
Asthma and chronic obstructive pulmonary disease (COPD) are both obstructive airway
diseases that involve chronic inflammation of the respiratory tract, but the type of inflammation is …
diseases that involve chronic inflammation of the respiratory tract, but the type of inflammation is …
[HTML][HTML] Decreased histone deacetylase activity in chronic obstructive pulmonary disease
Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic
airway inflammation that is greater in patients with advanced disease. We asked whether there …
airway inflammation that is greater in patients with advanced disease. We asked whether there …
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
Global strategy for asthma management and prevention: GINA executive summary
…, SS Hurd, PJ Barnes, J Bousquet… - European …, 2008 - Eur Respiratory Soc
Asthma is a serious health problem throughout the world. During the past two decades, many
scientific advances have improved our understanding of asthma and ability to manage and …
scientific advances have improved our understanding of asthma and ability to manage and …
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
…, TT Hansel, ST Holgate, PJ Sterk, PJ Barnes - The Lancet, 2000 - thelancet.com
Background Interleukin-5 (IL-5) is essential for the formation of eosinophils, which are thought
to have a major role in the pathogenesis of asthma and other allergic diseases. We aimed …
to have a major role in the pathogenesis of asthma and other allergic diseases. We aimed …